Results
|
221.
|
Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia. [electronic resource] by
- Sonneveld, P
- Burnett, A
- Vossebeld, P
- Ben-Am, M
- Rosenkranz, G
- Pfister, C
- Verhoef, G
- Dekker, A
- Ossenkoppele, G
- Ferrant, C
- Yin, L
- Gratwohl, A
- Kovacsovics, T
- Vellenga, E
- Capdeville, R
- Löwenberg, B
Producer: 20020610
In:
The hematology journal : the official journal of the European Haematology Association vol. 1
Availability: No items available.
|
|
222.
|
Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity. [electronic resource] by
- van Der Kolk, D M
- Vellenga, E
- van Der Veen, A Y
- Noordhoek, L
- Timmer-Bosscha, H
- Ossenkoppele, G J
- Raymakers, R A
- Müller, M
- van Den Berg, E
- de Vries, E G
Producer: 20000629
In:
Blood vol. 95
Availability: No items available.
|
|
223.
|
|
|
224.
|
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group. [electronic resource] by
- Löwenberg, B
- Suciu, S
- Archimbaud, E
- Ossenkoppele, G
- Verhoef, G E
- Vellenga, E
- Wijermans, P
- Berneman, Z
- Dekker, A W
- Stryckmans, P
- Schouten, H
- Jehn, U
- Muus, P
- Sonneveld, P
- Dardenne, M
- Zittoun, R
Producer: 19971112
In:
Blood vol. 90
Availability: No items available.
|
|
225.
|
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study. [electronic resource] by
- Vellenga, E
- van Agthoven, M
- Croockewit, A J
- Verdonck, L F
- Wijermans, P J
- van Oers, M H
- Volkers, C P
- van Imhoff, G W
- Kingma, T
- Uyl-de Groot, C A
- Fibbe, W E
Producer: 20010927
In:
British journal of haematology vol. 114
Availability: No items available.
|
|
226.
|
RFP2, c13ORF1, and FAM10A4 are the most likely tumor suppressor gene candidates for B-cell chronic lymphocytic leukemia. [electronic resource] by
- van Everdink, W J
- Baranova, A
- Lummen, C
- Tyazhelova, T
- Looman, M W G
- Ivanov, D
- Verlind, E
- Pestova, A
- Faber, H
- van der Veen, A Y
- Yankovsky, N
- Vellenga, E
- Buys, C H C M
Producer: 20031105
In:
Cancer genetics and cytogenetics vol. 146
Availability: No items available.
|
|
227.
|
Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests. [electronic resource] by
- Janssen, J J
- van Rijn, R S
- van der Holt, B
- Schuurhuis, G J
- Vellenga, E
- Verhoef, G E
- Ossenkoppele, G J
- van den Berg, E
- Hagemeijer, A
- Släter, R
- Nieuwint, A W
- Cornelissen, J J
Producer: 20000714
In:
Bone marrow transplantation vol. 25
Availability: No items available.
|
|
228.
|
Phase III efficacy study of interleukin-3 after autologous bone marrow transplantation in patients with malignant lymphoma. [electronic resource] by
- Brouwer, R E
- Vellenga, E
- Zwinderman, K H
- Bezwoda, W R
- Durrant, S T
- Herrmann, R P
- Kiese, B
- Maraninchi, D
- Milligan, D W
- Sklenar, I
- Tabilio, A
- Volonte, J L
- Winfield, D A
- Fibbe, W E
Producer: 19991026
In:
British journal of haematology vol. 106
Availability: No items available.
|
|
229.
|
Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Belgium-Dutch Hematology-Oncology Group. [electronic resource] by
- Willems, P
- Verhagen, O
- Segeren, C
- Veenhuizen, P
- Guikema, J
- Wiemer, E
- Groothuis, L
- Jong, T B
- Kok, H
- Bloem, A
- Bos, N
- Vellenga, E
- Mensink, E
- Sonneveld, P
- Lokhorst, H
- van Der Schoot, E
- Raymakers, R
Producer: 20000810
In:
Blood vol. 96
Availability: No items available.
|
|
230.
|
Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML. [electronic resource] by
- de Jonge, H J M
- Woolthuis, C M
- Vos, A Z
- Mulder, A
- van den Berg, E
- Kluin, P M
- van der Weide, K
- de Bont, E S J M
- Huls, G
- Vellenga, E
- Schuringa, J J
Producer: 20120131
In:
Leukemia vol. 25
Availability: No items available.
|
|
231.
|
Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts. [electronic resource] by
- van der Helm, L H
- Veeger, N J G M
- Kooy, M van Marwijk
- Beeker, A
- de Weerdt, O
- de Groot, M
- Alhan, C
- Hoogendoorn, M
- Laterveer, L
- van de Loosdrecht, A A
- Koedam, J
- Vellenga, E
- Huls, G
Producer: 20130917
In:
Leukemia research vol. 37
Availability: No items available.
|
|
232.
|
|
|
233.
|
Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia. [electronic resource] by
- Vellenga, E
- Uyl-de Groot, C A
- de Wit, R
- Keizer, H J
- Löwenberg, B
- ten Haaft, M A
- de Witte, T J
- Verhagen, C A
- Stoter, G J
- Rutten, F F
- Mulder, N H
- Smid, W M
- de Vries, E G
Producer: 19960709
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 14
Availability: No items available.
|
|
234.
|
The role of oral mucositis on the systemic inflammation parameter IL-8 in febrile neutropenic cancer patients. [electronic resource] by
- Stokman, M A
- Oude Nijhuis, C S M
- Spijkervet, F K L
- de Bont, E S J M
- Dijkstra, P U
- Daenen, S M G J
- Gietema, J A
- van der Graaf, W T A
- Groen, H J M
- Vellenga, E
- Kamps, W A
Producer: 20061103
In:
Cancer investigation vol. 24
Availability: No items available.
|
|
235.
|
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia. [electronic resource] by
- Löwenberg, B
- Boogaerts, M A
- Daenen, S M
- Verhoef, G E
- Hagenbeek, A
- Vellenga, E
- Ossenkoppele, G J
- Huijgens, P C
- Verdonck, L F
- van der Lelie, J
- Wielenga, J J
- Schouten, H C
- Gmür, J
- Gratwohl, A
- Hess, U
- Fey, M F
- van Putten, W L
Producer: 19971217
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 15
Availability: No items available.
|
|
236.
|
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia? [electronic resource] by
- Vellenga, E
- van Putten, W L
- Boogaerts, M A
- Daenen, S M
- Verhoef, G E
- Hagenbeek, A
- Jonkhoff, A R
- Huijgens, P C
- Verdonck, L F
- van der Lelie, J
- Schouten, H C
- Gmür, J
- Wijermans, P
- Gratwohl, A
- Hess, U
- Fey, M F
- Löwenberg, B
Producer: 19990908
In:
Bone marrow transplantation vol. 23
Availability: No items available.
|
|
237.
|
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia. [electronic resource] by
- Craddock, C
- Versluis, J
- Labopin, M
- Socie, G
- Huynh, A
- Deconinck, E
- Volin, L
- Milpied, N
- Bourhis, J H
- Rambaldi, A
- Chevallier, P
- Blaise, D
- Manz, M
- Vellenga, E
- Vekemans, M-C
- Maertens, J
- Passweg, J
- Vyas, P
- Schmid, C
- Löwenberg, B
- Ossenkoppele, G
- Mohty, M
- Cornelissen, J J
- Nagler, A
Producer: 20190916
In:
Journal of internal medicine vol. 283
Availability: No items available.
|
|
238.
|
Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy. [electronic resource] by
- Martínez-Cuadrón, D
- Montesinos, P
- Vellenga, E
- Bernal, T
- Salamero, O
- Holowiecka, A
- Brunet, S
- Gil, C
- Benavente, C
- Ribera, J M
- Pérez-Encinas, M
- De la Serna, J
- Esteve, J
- Rubio, V
- González-Campos, J
- Escoda, L
- Amutio, M E
- Arnan, M
- Arias, J
- Negri, S
- Lowënberg, B
- Sanz, M A
Producer: 20181211
In:
Leukemia vol. 32
Availability: No items available.
|
|
239.
|
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma. [electronic resource] by
- Segeren, C M
- Sonneveld, P
- van der Holt, B
- Baars, J W
- Biesma, D H
- Cornellissen, J J
- Croockewit, A J
- Dekker, A W
- Fibbe, W E
- Löwenberg, B
- van Marwijk Kooy, M
- van Oers, M H
- Richel, D J
- Schouten, H C
- Vellenga, E
- Verhoef, G E
- Wijermans, P W
- Wittebol, S
- Lokhorst, H M
Producer: 19990610
In:
British journal of haematology vol. 105
Availability: No items available.
|
|
240.
|
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio. [electronic resource] by
- Versluis, J
- In 't Hout, F E M
- Devillier, R
- van Putten, W L J
- Manz, M G
- Vekemans, M-C
- Legdeur, M-C
- Passweg, J R
- Maertens, J
- Kuball, J
- Biemond, B J
- Valk, P J M
- van der Reijden, B A
- Meloni, G
- Schouten, H C
- Vellenga, E
- Pabst, T
- Willemze, R
- Löwenberg, B
- Ossenkoppele, G
- Baron, F
- Huls, G
- Cornelissen, J J
Producer: 20170830
In:
Leukemia vol. 31
Availability: No items available.
|